CNX Coal Resources LP (NYSE:CNXC) Receives $14.83 Average PT from Analysts
CNX Coal Resources LP (NYSE:CNXC) has earned a consensus recommendation of “Hold” from the seven analysts that are presently covering the company. Four investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $14.40.
Several research analysts have weighed in on the company. Zacks Investment Research raised CNX Coal Resources from a “hold” rating to a “buy” rating and set a $11.00 target price on the stock in a research report on Wednesday, July 13th. Jefferies Group upped their target price on CNX Coal Resources from $13.00 to $15.00 and gave the stock a “hold” rating in a research report on Tuesday, September 20th. Stifel Nicolaus upped their target price on CNX Coal Resources from $15.00 to $17.00 and gave the stock a “buy” rating in a research report on Thursday, July 28th. Finally, Citigroup Inc. assumed coverage on CNX Coal Resources in a research report on Thursday, July 28th. They issued a “neutral” rating and a $14.00 target price on the stock.
Shares of CNX Coal Resources (NYSE:CNXC) opened at 15.29 on Monday. CNX Coal Resources has a 52 week low of $5.98 and a 52 week high of $15.55. The stock’s 50 day moving average is $13.63 and its 200 day moving average is $10.17. The stock has a market cap of $355.06 million, a price-to-earnings ratio of 637.08 and a beta of 2.08.
CNX Coal Resources (NYSE:CNXC) last posted its quarterly earnings results on Friday, July 29th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.13 by $0.02. CNX Coal Resources had a net margin of 12.85% and a return on equity of 16.14%. On average, equities analysts forecast that CNX Coal Resources will post $0.85 EPS for the current year.
Hedge funds have recently added to or reduced their stakes in the company. Howard Hughes Medical Institute increased its stake in CNX Coal Resources by 20.4% in the first quarter. Howard Hughes Medical Institute now owns 37,552 shares of the company’s stock valued at $270,000 after buying an additional 6,353 shares during the period. A.R.T. Advisors LLC bought a new stake in CNX Coal Resources during the second quarter valued at about $150,000. Renaissance Technologies LLC bought a new stake in CNX Coal Resources during the first quarter valued at about $698,000. Finally, Mountain Lake Investment Management LLC increased its stake in CNX Coal Resources by 31.8% in the first quarter. Mountain Lake Investment Management LLC now owns 425,000 shares of the company’s stock valued at $3,052,000 after buying an additional 102,500 shares during the period. Institutional investors own 59.04% of the company’s stock.
CNX Coal Resources Company Profile
CNX Coal Resources LP is a producer of thermal coal in the Northern Appalachian Basin and the eastern United States. The Company is engaged in the management and development of the thermal coal operations of CONSOL Energy Inc (CONSOL Energy) in Pennsylvania. The Company’s assets include interests in CONSOL Energy’s Pennsylvania mining complex, which consists of approximately three underground mines and related infrastructure that produce bituminous thermal coal that is sold primarily to electric utilities in the eastern United States.
Receive News & Stock Ratings for CNX Coal Resources LP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CNX Coal Resources LP and related stocks with our FREE daily email newsletter.